anti-CMV therapeutics (Inhibitex/Welsh School of Pharmacy)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-CMV therapeutics (Inhibitex/Welsh School of Pharmacy)
Drug Alias Nameanti-CMV therapeutics (FermaVir/Welsh School of Pharmacy)anti-cytomegalovirus therapeutics (FermaVir/Welsh School of Pharmacy)CF-2095
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWestern Europe
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWelsh School of Pharmacy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFermavir Pharmaceuticals LlcWelsh School of PharmacyInhibitex Llc
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A